Dr. Abhinav Agrawal, MD

Dr. Agrawal practices at Long Island Jewish Medical Center in New Hyde Park, New York.

Dr. Agrawal's NPI, 1487094082, was assigned on June 27, 2013. Dr. Agrawal graduated from Other in 2011. Dr. Agrawal holds New York license 284844.

Dr. Agrawal's primary practice is Long Island Jewish Medical Center, at 27005 76th Ave, New Hyde Park, NY 11040 in Nassau County. The practice phone is (516) 876-6000.

Dr. Agrawal's primary practice is Long Island Jewish Medical Center in New Hyde Park, New York. Dr. Agrawal is also affiliated with Long Island Jewish Medical Center. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Agrawal to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agrawal practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Agrawal's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Agrawal's licenses on file in 2 states: New York and Illinois.

CMS data shows 1,387 Medicare services from Dr. Agrawal across 26 procedure codes in 2024, for 342 Medicare patients. Medicare paid $139,232 for them.

CMS counts 342 Medicare patients who saw Dr. Agrawal in 2024. The largest group is 75 to 84, with 139 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agrawal's median patient age at 70, with 48% women.

In 2024, Dr. Agrawal wrote 119 Medicare Part D claims for 41 patients. 62% of them were for generic drugs. CMS names the drug for 71 of them, across 4 drugs with 11 or more claims each, at $18,793 in total drug cost. In 2023, CMS named 21 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Agrawal for performance year 2024, reported through an alternative payment model (APM). Dr. Agrawal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Agrawal as offering telehealth.

Dmand AI links 97 papers to Dr. Agrawal, published from 2010 to 2025. 2016 was the busiest year, with 8. The most frequent topics are Bronchoscopy, Pleural Effusion and Diagnosis, Differential. Dr. Agrawal has published most often in Respir Med. Dr. Agrawal's most frequent co-authors are Udit Sudhir Chaddha, MD, Septimiu Murgu and Rutuja Rajanikant Sikachi, MD.

Dmand AI links Dr. Agrawal to 1 clinical trial. Conditions studied include Pleural Effusion and Pleural Diseases.

CMS Open Payments shows 114 general payments to Dr. Agrawal from 17 drug and device companies from 2016 to 2025. Grants make up the largest share, 73% of the total. Boston Scientific Corporation paid the most, $32,503.

Dr. Agrawal graduated from Other in 2011.